Mumbai, August 30, 2014: Market regulator Sebi today slapped a fine of Rs 3 lakh on Sun Pharma Advanced Research’s promoter group entity for allegedly failing to make shareholding disclosures within stipulated timeline.
The Securities and Exchange Board of India (Sebi), in its order, has imposed a penalty on Virtuous Share Investments “which will be commensurate with the violation committed by it”.
According to the regulator, pursuant to the rights issue, Sun Pharma Advanced Research Ltd had allotted 16.5 lakh partly paid-up shares to Virtuous Share Investments on October 3, 2012.
Consequently, shareholding of Virtuous Share Investments rose from 1.03 crore shares, amounting to 4.98 per cent stake of Sun Pharma Advanced Research, to 1.19 crore scrips or 5.06 per cent holding. The intimation of receipt of allotment was received by the promoter entity on October 10, 2012.
Virtuous Share Investments was required to disclose its shareholding to the company within two days from the receipt of intimation of allotment of shares (by October 12, 2012).
However, Sebi alleged the promoter group firm failed to make the disclosures within the prescribed timeline.
“The disclosure…was made by the noticee (Virtuous Share Investments) with a delay of more than a month,” Sebi said.Economics Times
SS Innovations marks a historic milestone with the successful completion of Indonesia’s first robotic cardiac…
Bangalore, November 27, 2024: In a heartening celebration of Kannada Rajyotsava 2024, Bangalore Hospitals hosted a…
New Delhi, November 27, 2024: Elevating the education of spinal surgery and treatment of spinal injuries…
New Delhi, November 27, 2024: In the ten years since stool transplant therapy, also known as…
Hyderabad, November 22, 2024: CARE Hospitals, Nampally, successfully hosted the 12th National Infection Prevention and Control (IPC)…
Bengaluru, November 22, 2024: Fortis Hospital, Cunningham Road successfully performed a life-enhancing robot-assisted kidney transplant on 61-year-old…